KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Payables (2016 - 2025)

Medpace Holdings' Payables history spans 11 years, with the latest figure at $28.1 million for Q4 2025.

  • For Q4 2025, Payables fell 13.48% year-over-year to $28.1 million; the TTM value through Dec 2025 reached $28.1 million, down 13.48%, while the annual FY2025 figure was $28.1 million, 13.48% down from the prior year.
  • Payables reached $28.1 million in Q4 2025 per MEDP's latest filing, up from $26.5 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $278.5 million in Q2 2022 to a low of $21.3 million in Q1 2021.
  • Average Payables over 5 years is $61.1 million, with a median of $28.6 million recorded in 2023.
  • Peak YoY movement for Payables: soared 1093.95% in 2022, then crashed 83.96% in 2024.
  • A 5-year view of Payables shows it stood at $25.7 million in 2021, then skyrocketed by 223.5% to $83.1 million in 2022, then plummeted by 61.64% to $31.9 million in 2023, then grew by 2.07% to $32.5 million in 2024, then dropped by 13.48% to $28.1 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Payables are $28.1 million (Q4 2025), $26.5 million (Q3 2025), and $43.3 million (Q2 2025).